T1	Participants 37 59	adult cancer survivors
T2	Participants 98 247	conducted 2010-2013) was to determine the efficacy of two common types of tobacco quitlines in adult cancer survivors who regularly smoked cigarettes
T3	Participants 288 341	Memphis, Tennessee (n=427, 67% female, 60% Caucasian)
T4	Participants 605 622	smoking cessation
T5	Participants 632 671	While 12-month self-reported abstinence
T6	Participants 1425 1465	smoking cessation among cancer survivors
